Syndax Pharmaceuticals Inc (SNDX) returns
Syndax Pharmaceuticals returns over 10 years
$1,000 invested in Syndax Pharmaceuticals ten years ago was worth $1,145 at the close on October 30, 2026, with dividends reinvested: an average return of 1.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -27.4% | — | $726.06 | -0.9% |
| 3 months | -29.9% | — | $700.72 | +2.1% |
| Year to date | -35.0% | — | $649.69 | +11.7% |
| 1 year | +1.9% | — | $1,019 | +12.4% |
| 3 years | +4.6% | +1.5% | $1,046 | +88.5% |
| 5 years | -29.8% | -6.8% | $701.80 | +76.0% |
| 10 years | +14.5% | +1.4% | $1,145 | +316.6% |
Syndax Pharmaceuticals return by calendar year
| Year | SNDX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -35.0% | +11.7% | -46.7% |
| 2025 | +58.9% | +17.7% | +41.2% |
| 2024 | -38.8% | +24.9% | -63.7% |
| 2023 | -15.1% | +26.2% | -41.3% |
| 2022 | +16.3% | -18.2% | +34.4% |
| 2021 | -1.6% | +28.7% | -30.3% |
| 2020 | +153.3% | +18.4% | +134.9% |
| 2019 | +97.3% | +31.2% | +66.1% |
| 2018 | -49.2% | -4.6% | -44.6% |
| 2017 | +22.2% | +21.7% | +0.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: SNDX financials
No forecast, no recommendation. This page describes Syndax Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.